Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DSwiss (DQWS) Shares Outstanding (Weighted Average) (2016 - 2025)

DSwiss has reported Shares Outstanding (Weighted Average) over the past 11 years, most recently at $206.9 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.0% to $206.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $206.9 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $206.9 million for FY2025, 0.0% changed from the prior year.
  • Shares Outstanding (Weighted Average) was $206.9 million for Q4 2025 at DSwiss, roughly flat from $206.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $206.9 million in Q1 2021 and troughed at $206.9 million in Q4 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $206.9 million (2021), against an average of $206.9 million.
  • The largest YoY upside for Shares Outstanding (Weighted Average) was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $206.9 million in 2021, then changed by 0.0% to $206.9 million in 2022, then changed by 0.0% to $206.9 million in 2023, then changed by 0.0% to $206.9 million in 2024, then changed by 0.0% to $206.9 million in 2025.
  • Per Business Quant, the three most recent readings for DQWS's Shares Outstanding (Weighted Average) are $206.9 million (Q4 2025), $206.9 million (Q3 2025), and $206.9 million (Q2 2025).